JP2025503637A5 - - Google Patents
Info
- Publication number
- JP2025503637A5 JP2025503637A5 JP2024541135A JP2024541135A JP2025503637A5 JP 2025503637 A5 JP2025503637 A5 JP 2025503637A5 JP 2024541135 A JP2024541135 A JP 2024541135A JP 2024541135 A JP2024541135 A JP 2024541135A JP 2025503637 A5 JP2025503637 A5 JP 2025503637A5
- Authority
- JP
- Japan
- Prior art keywords
- expression cassette
- antibody expression
- promoter
- antibody
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263297787P | 2022-01-09 | 2022-01-09 | |
| US63/297,787 | 2022-01-09 | ||
| US202263374878P | 2022-09-07 | 2022-09-07 | |
| US63/374,878 | 2022-09-07 | ||
| PCT/US2023/060329 WO2023133561A1 (en) | 2022-01-09 | 2023-01-09 | Vector constructs for delivery of nucleic acids encoding therapeutic anti-igf-1r antibodies and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503637A JP2025503637A (ja) | 2025-02-04 |
| JP2025503637A5 true JP2025503637A5 (enExample) | 2026-01-14 |
Family
ID=85383021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541135A Pending JP2025503637A (ja) | 2022-01-09 | 2023-01-09 | 治療用抗ｉｇｆ－１ｒ抗体をコードする核酸の送達のためのベクター構築物およびそれを使用する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250084434A1 (enExample) |
| EP (1) | EP4460522A1 (enExample) |
| JP (1) | JP2025503637A (enExample) |
| KR (1) | KR20240130139A (enExample) |
| AU (1) | AU2023205804A1 (enExample) |
| CA (1) | CA3247783A1 (enExample) |
| CO (1) | CO2024010847A2 (enExample) |
| IL (1) | IL314154A (enExample) |
| MX (1) | MX2024008509A (enExample) |
| WO (1) | WO2023133561A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3195512A1 (en) | 2020-10-14 | 2022-04-21 | Vahe Bedian | Compositions and methods for treatment of thyroid eye disease |
| JP2024531151A (ja) | 2021-08-10 | 2024-08-29 | ビリジアン セラピューティクス， インコーポレイテッド | 甲状腺眼疾患の処置のための組成物、用量および方法 |
| AU2024287813A1 (en) | 2023-07-07 | 2026-01-22 | Kriya Therapeutics, Inc. | Periocular delivery of aav vectors for treating ophthalmic pathologies |
| WO2025039622A1 (zh) * | 2023-08-23 | 2025-02-27 | 上海金珂博生物技术有限公司 | 经修饰的腺相关病毒载体及其在治疗中枢神经系统疾病中的用途 |
| CN122122186A (zh) * | 2023-09-06 | 2026-05-29 | 维里迪安治疗公司 | 抗igf-1r抗体的药物组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
| US5356806A (en) | 1987-06-05 | 1994-10-18 | The United States Of America As Represented By The Department Of Health And Human Services | Immortalized human cell lines containing exogenous cytochrome P450 |
| US4937190A (en) | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
| US6174666B1 (en) | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
| US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| US5527928A (en) | 1994-09-30 | 1996-06-18 | Nantz; Michael H. | Cationic transport reagents |
| US5892071A (en) | 1994-09-30 | 1999-04-06 | The Reagents Of The University Of California | Cationic transport reagents |
| US5869715A (en) | 1995-09-27 | 1999-02-09 | The Reagents Of The University Of California | Polyfunctional cationic cytofectins |
| EP1390490B1 (en) | 2001-05-24 | 2009-04-15 | Genzyme Corporation | Muscle-specific expression vectors |
| MXPA04011624A (es) * | 2002-05-24 | 2005-03-07 | Schering Corp | Anticuerpo neutralizante humano anti-igfr. |
| AR046071A1 (es) | 2003-07-10 | 2005-11-23 | Hoffmann La Roche | Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos |
| CN101528916B (zh) | 2006-04-28 | 2013-09-04 | 宾夕法尼亚大学托管会 | 规模可调的aav生产方法 |
| JP2012515556A (ja) | 2009-01-23 | 2012-07-12 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 低下したエフェクタ機能を有する安定化Ｆｃポリペプチドおよび使用方法 |
| EP4667578A3 (en) * | 2019-04-03 | 2026-04-01 | REGENXBIO Inc. | Gene therapy for eye pathologies |
-
2023
- 2023-01-09 JP JP2024541135A patent/JP2025503637A/ja active Pending
- 2023-01-09 EP EP23707576.7A patent/EP4460522A1/en active Pending
- 2023-01-09 KR KR1020247026536A patent/KR20240130139A/ko active Pending
- 2023-01-09 US US18/727,201 patent/US20250084434A1/en active Pending
- 2023-01-09 WO PCT/US2023/060329 patent/WO2023133561A1/en not_active Ceased
- 2023-01-09 MX MX2024008509A patent/MX2024008509A/es unknown
- 2023-01-09 IL IL314154A patent/IL314154A/en unknown
- 2023-01-09 CA CA3247783A patent/CA3247783A1/en active Pending
- 2023-01-09 AU AU2023205804A patent/AU2023205804A1/en active Pending
-
2024
- 2024-08-09 CO CONC2024/0010847A patent/CO2024010847A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7390426B2 (ja) | β－サルコグリカン及びマイクロＲＮＡ－２９のアデノ随伴ウイルスベクター送達ならびに筋ジストロフィーの治療 | |
| TWI878204B (zh) | 腺相關病毒載體遞送肌肉特異性微小肌縮蛋白以治療肌肉萎縮症 | |
| JP2020513811A5 (enExample) | ||
| AU2025271096A1 (en) | A modified mGluR6 promoter and methods of use | |
| JP2023545424A5 (enExample) | ||
| JP2008506389A (ja) | Ａａｖベクター組成物および免疫グロブリンの発現の増強のための方法ならびにその使用方法 | |
| IL320714A (en) | Gene therapy for limb-girdle muscular dystrophy type 2c | |
| JP2021512072A5 (enExample) | ||
| JP2022529775A5 (enExample) | ||
| EP3596112A2 (en) | Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy | |
| RU2017115477A (ru) | Полинуклеотиды aadc для лечения болезни паркинсона | |
| JP2021533805A5 (enExample) | ||
| JP2022539156A (ja) | ヒアルロン酸を用いた眼組織へのａａｖ媒介形質導入の増強 | |
| WO2020039425A1 (en) | Vectors expressing klotho for treating cancer | |
| CA3247783A1 (en) | Vector constructs for delivery of nucleic acids encoding therapeutic anti-igf-1r antibodies and methods of using the same | |
| JP2022531892A5 (enExample) | ||
| JP2020519251A5 (enExample) | ||
| CN117587027A (zh) | 编码抗vegf的抗体或抗原结合片段的多核苷酸表达盒及质粒 | |
| JP7684296B2 (ja) | Ｉｇｈｍｂｐ２遺伝子に関連する障害の治療のための材料および方法 | |
| EP4355766A1 (en) | Gene therapy for tuberous sclerosis | |
| US20260022397A1 (en) | Adeno-associated virus vectors and methods of their use for reducing the risk of, treating, and preventing metastasis | |
| US20260021206A1 (en) | Adeno-associated virus vectors and methods of their use for reducing the risk of, treating, and preventing metastasis | |
| CN117587028A (zh) | 编码抗vegf的抗体或抗原结合片段的多核苷酸表达盒及质粒 | |
| TH1901005769A (th) | การนำส่งเวกเตอร์ของไวรัสที่เกี่ยวเนื่องกับอะดีโนแก่ไมโคร-ดิสโทรฟินที่จำเพาะกับกล้ามเนื้อเพื่อรักษาโรคกล้ามเนื้อเสื่อม | |
| TW202432835A (zh) | 使用aav載體之斑菲素蛋白-2(pkp2)基因療法 |